One-pot syntheses of immunostimulatory glycolipids.
Glycolipids containing alpha-linked galactosyl and glucosyl moieties have been shown to possess unique immunostimulatory activity creating a need for access to diverse and anomerically pure sources of these compounds for immunological studies. To meet this demand, glycosyl iodides were enlisted in the synthesis of these biologically relevant glycoconjugates. In the first-generation protocol, per-O-benzyl galactosyl iodide was efficiently coupled with activated sphingosine acceptors, but fully functionalized ceramides were found to be unreactive. To overcome this obstacle, per-O-trimethylsilyl glycosyl iodides were investigated and shown to undergo highly efficient coupling with ceramide and glycerol ester acceptors. Contrary to what has been observed with other donors, we detected little difference between the reactivity of glucosyl and galactosyl iodides. The trimethylsilyl protecting groups play a dual role in activating the donor toward nucleophilic attack while at the same time providing transient protection: the silyl groups are readily removed upon methanolysis. All reactions proceeded with complete acceptor regioselectivity, eliminating the need for additional protecting group manipulations, and the desired alpha-anomers were formed exclusively. This three-step, one-pot synthetic platform provides rapid access to an important class of immunostimulatory molecules including the first reported synthesis of the glucosyl analogue of the bacterial antigen BbGL-II.
Schombs
Matthew
M
Department of Chemistry, University of California, Davis, One Shields Avenue, Davis, California 95616, USA.
Park
Francine E
FE
Du
Wenjun
W
Kulkarni
Suvarn S
SS
Gervay-Hague
Jacquelyn
J
D006017:Glycolipids / Q000138:chemical synthesis* / Q000494:pharmacology; D007107:Immune System / Q000187:drug effects*; D013329:Structure-Activity Relationship
D006017:Glycolipids
J Org Chem. 2004 Oct 29;69(22):7758-60
15498011
Trends Pharmacol Sci. 2005 May;26(5):252-7
15860372
Chem Biol. 2008 Jul 21;15(7):654-64
18635002
Nat Rev Immunol. 2009 Jan;9(1):28-38
19079136
Acc Chem Res. 2006 Apr;39(4):259-65
16618093
J Am Chem Soc. 2008 Dec 10;130(49):16468-9
19554718
J Am Chem Soc. 2007 Jul 25;129(29):9222-35
17602482
Biochimie. 2001 Jul;83(7):683-92
11522398
Chem Soc Rev. 2006 Sep;35(9):771-9
16936925
Nat Immunol. 2006 Sep;7(9):904-6
16924252
J Med Chem. 1998 Feb 12;41(4):650-2
9484513
Org Lett. 2006 Dec 7;8(25):5765-8
17134267
Org Lett. 2005 May 12;7(10):2063-5
15876055
Nat Immunol. 2006 Sep;7(9):978-86
16921381
Org Lett. 2001 Jun 28;3(13):2081-4
11418054
J Am Chem Soc. 2006 Jul 19;128(28):9022-3
16834361
Nat Immunol. 2005 Aug;6(8):810-8
16007091
J Org Chem. 2003 Oct 17;68(21):8142-8
14535796
Biochem Mol Biol Int. 1995 May;36(1):21-30
7663417
MMWR CDC Surveill Summ. 2000 Apr 28;49(3):1-11
10817483
Nature. 2005 Mar 24;434(7032):520-5
15791257
Nature. 2001 Oct 4;413(6855):531-4
11586362
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1351-6
15665086
Chem Commun (Camb). 2007 Jun 21;(23):2336-8
17844738
J Exp Med. 2002 Mar 4;195(5):617-24
11877484
Science. 1997 Nov 28;278(5343):1626-9
9374463
Bioorg Med Chem. 2008 Feb 1;16(3):1073-83
18006319
Langmuir. 2009 Apr 21;25(8):4595-600
19249826